Lumino is a digital therapeutics startup founded in 2020 that aims to provide scalable and sustainable healthcare interventions with the mission "For better care. For all." Headquartered in the United Kingdom, specifically in Bristol and Glasgow, the company operates within the Health Care and Health and Wellness industries.
Supported by notable entities such as the Scottish Government, NHS partners, Innovate UK, NIHR, Bayer, and SBRI Wales, Lumino has established solid governmental and industry backing, which underscores its credibility and strategic importance in the field of healthcare innovation. The company's most recent financial activity was a grant investment on 01 April 2023, signalling ongoing confidence from institutional investors despite limited disclosed details on the investment specifics.
With a focus on digital solutions, Lumino positions itself as a promising player tackling healthcare accessibility and effectiveness at scale, potentially offering substantial returns and impact for early-stage investors seeking to influence the future of health tech.